Jack Meehan analyst BARCLAYS

Currently out of the existing stock ratings of Jack Meehan, 33 are a BUY (57.89%), 13 are a HOLD (22.81%), 11 are a SELL (19.3%).

Jack Meehan

Work Performance Price Targets & Ratings Chart

Analyst Jack Meehan works at BARCLAYS with a stock forecast success ratio of 98.72% fulfilled within 234.54 days on average.

Jack Meehan’s has documented 127 price targets and ratings displayed on 13 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on A, Agilent Technologies at 28-Feb-2024.

Wall Street Analyst Jack Meehan

Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for INMD (INMODE LTD) at 11/6/2019. The price target of $22.5 was fulfilled within 5 days with a profit of $3.07 (15.8%) receiving and performance score of 31.6.

Average potential price target upside

HOLX Hologic MYGN Myriad Genetics PDD Pinduoduo A Agilent Technologies TMO Thermo Fisher Scientific DGX Quest Diagnostics orporated ILMN Illumina QGEN Qiagen NV BIO Bio-Rad Laboratories INMD InMode Ltd IQV IQVIA Holdings MTD Mettler-Toledo International WAT Waters

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

88

$10.65 (13.77%)

85

1 months 27 days ago

3/7 (42.86%)

$15.56 (21.48%)

270

Buy

90

$12.65 (16.35%)

83

1 months 27 days ago

13/18 (72.22%)

$17.56 (24.24%)

159

82

$4.65 (6.01%)

86

4 months 16 days ago

4/7 (57.14%)

$10.6 (14.85%)

14

Hold

73

$-4.35 (-5.62%)

80

4 months 19 days ago

13/15 (86.67%)

$0.87 (1.21%)

219

Buy

85

$7.65 (9.89%)

95

5 months 12 days ago

2/7 (28.57%)

$16 (23.19%)

43

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jack Meehan is most bullish on?

Potential upside of $-22.37 has been obtained for A (AGILENT TECHNOLOGIES)

What Year was the first public recommendation made by Jack Meehan?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?